Logo

American Heart Association

  2
  0


Final ID: Su4007

Application and Outcomes of Coronary Atherectomy in Patients with Acute Coronary Syndrome: A Report from the Nationwide J-PCI Registry

Abstract Body (Do not enter title and authors here): Introduction: Acute coronary syndrome (ACS) has been generally considered a relative contraindication to coronary atherectomy.
Aims: The objective of this study was to investigate the temporal trends and hospital variability in the use of coronary atherectomy and its outcomes among patients undergoing percutaneous coronary intervention (PCI) for ACS from a nationwide PCI registry in Japan.
Methods: First, we analyzed the temporal trend in the use of rotational atherectomy (RA) and orbital atherectomy (OA) during PCI for ACS patients between 2014 and 2022 (822,237 PCIs from 1,269 hospitals). Next, we assessed the outcomes of the patients who underwent RA for ACS between 2019 and 2022 (7,421 patients across 662 hospitals). The primary outcome was in-hospital mortality after PCI. Patient outcomes associated with hospital PCI volumes and the device policy change on coronary atherectomy in Japan in 2020, which allowed operators to perform coronary atherectomy without on-site surgical backup, were also evaluated.
Results: The rate of RA for ACS was low at 2.0% in the overall cohort (16,264/822,237 PCIs); the rate slightly increased from 1.9% in 2014-2019 to 2.1% in 2020-2022 (after the device policy change). The rate of PCI with OA for ACS was also low at 0.8% in 2021-2022 (1,404/185,141 PCIs). Increasing the complexity of baseline characteristics, including advanced age, diabetes, chronic kidney disease, dialysis, peripheral arterial disease, prior coronary artery bypass grafting, ST-segment elevation myocardial infarction, cardiac arrest within 24 h, cardiogenic shock within 24 h, three-vessel disease, and mechanical circulatory support during PCI was significantly associated with increased in-hospital mortality after PCI with RA in ACS patients (P<0.05 for all). Annual hospital PCI volumes (odds ratio, 0.937; 95% CI, 0.653-1.361; P=0.729 for high- vs. low-volume hospitals) and newcomer facilities starting RA after the device policy change (odds ratio, 0.987; 95% CI, 0.651-1.361; P=0.951) were not significantly associated with in-hospital outcomes after RA for ACS.
Conclusions: The present study using a nationwide multicenter PCI registry showed that the overall rate of PCI with coronary atherectomy for ACS was low but slightly increased after the device policy change in Japan. Hospital PCI volumes and newly accredited facilities on coronary atherectomy after the device policy change were not associated with in-hospital outcomes after RA for ACS.
  • Aikawa, Tadao  ( Juntendo University , Tokyo , Japan )
  • Minamino, Tohru  ( Juntendo University , Tokyo , Japan )
  • Mori, Yuichiro  ( Kyoto Univ Grad School of Medicine , Kyoto , Japan )
  • Kohsaka, Shun  ( Keio University School of Medicine , Tokyo , Japan )
  • Matsue, Yuya  ( Juntendo University , Tokyo , Japan )
  • Kuno, Toshiki  ( Montefiore Medical Center , Bronx , New York , United States )
  • Yamaji, Kyohei  ( Kyoto University Hospital , Kyoto , Japan )
  • Ozaki, Dai  ( Juntendo University Urayasu Hospital , Urayasu , Japan )
  • Tokano, Takashi  ( Juntendo University Urayasu Hospital , Urayasu , Japan )
  • Kozuma, Ken  ( TEIKYO UNIVERSITY , Tokyo , Japan )
  • Author Disclosures:
    Tadao Aikawa: DO NOT have relevant financial relationships | Tohru Minamino: No Answer | Yuichiro Mori: DO NOT have relevant financial relationships | Shun Kohsaka: No Answer | Yuya Matsue: DO have relevant financial relationships ; Speaker:Otsuka Pharmaceutical Co., EN Otsuka Pharmaceutical Co., Novartis Pharma K.K., Bayer Inc., Pfizer Japan Inc., Nippon Boehringer Ingelheim Co., and AstraZeneca:Past (completed) ; Research Funding (PI or named investigator):Pfizer Japan Inc., Otsuka Pharmaceutical Co, EN Otsuka Pharmaceutical Co., Ltd., and Nippon Boehringer Ingelheim Co., Ltd :Active (exists now) | Toshiki Kuno: DO NOT have relevant financial relationships | Kyohei Yamaji: DO NOT have relevant financial relationships | Dai Ozaki: DO NOT have relevant financial relationships | Takashi Tokano: DO NOT have relevant financial relationships | Ken Kozuma: No Answer
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Interventional Considerations in the ACS Patient

Sunday, 11/17/2024 , 11:30AM - 12:30PM

Abstract Poster Session

More abstracts on this topic:
Double Guiding Catheter Technique for Orbital Atherectomy in a Heavily Calcified Coronary Bifurcation Using Microcatheter Protection for Non-atherectomy Wire

Yinadsawaphan Thanaboon, Kulthamrongsri Narathorn, Baquero Giselle

Association of Elevated Lipoprotein(a) Levels with Adverse Outcomes in Patients with Stable Angina Undergoing Stent-less PCI with Paclitaxel-coated Balloon

Takahashi Tomonori, Yamaguchi Koji, Yagi Shusuke, Yamada Hirotsugu, Soeki Takeshi, Sata Masataka, Wakatsuki Tetsuzo, Saijo Yoshihiro, Kawabata Yutaka, Ueno Rie, Kadota Muneyuki, Hara Tomoya, Matsuura Tomomi, Ise Takayuki

More abstracts from these authors:
Transcatheter versus Surgical Tricuspid Repair among Medicare Beneficiaries: One-Year Results

Shimoda Tomonari, Ueyama Hiroki, Miyamoto Yoshihisa, Watanabe Atsuyuki, Gotanda Hiroshi, Tsugawa Yusuke, Kuno Toshiki

Effect of early nutritional guidance for patients with acute myocardial infarction: A single center retrospective cohort study

Abe Hiroshi, Takasu Kiyoshi, Takamura Kazuhisa, Tokano Takashi, Minamino Tohru, Miyazaki Tetsuro, Yasuda Kentaro, Ishiwata Sayaki, Maki Masaaki, Shimai Ryousuke, Isogai Hiroyuki, Ozaki Dai, Nishiyama Hiroki

You have to be authorized to contact abstract author. Please, Login
Not Available